Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
2.36
0.46 (24.21%)
At close: Jun 16, 2025, 3:59 PM
2.55
8.05%
Pre-market: Jun 17, 2025, 04:04 AM EDT
24.21% (1D)
| Bid | 2.39 |
| Market Cap | 84.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -61.77M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | -1.14 |
| Analyst | Buy |
| Ask | 2.58 |
| Volume | 1,595,318 |
| Avg. Volume (20D) | 218,969 |
| Open | 2.10 |
| Previous Close | 1.90 |
| Day's Range | 2.12 - 2.40 |
| 52-Week Range | 1.00 - 3.83 |
| Beta | 0.00 |
About IMRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
+24.74%
Immuneering shares are trading higher after the co...
Unlock content with
Pro Subscription
2 months ago
+9.09%
Immuneering shares are trading higher. Needham reiterated a Buy rating on the stock.
